Novo A/S as of June 30, 2015
Portfolio Holdings for Novo A/S
Novo A/S holds 19 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 22.9 | $319M | 3.0M | 107.02 | |
| Ophthotech | 18.4 | $256M | 4.9M | 52.06 | |
| Inogen (INGN) | 11.4 | $158M | 3.5M | 44.60 | |
| Wright Medical Group Contingent Value Rights (Principal) | 8.9 | $124M | 4.7M | 26.26 | |
| Vanguard Intl Equity Index F Ftse Europe Etf (VGK) | 8.2 | $113M | 2.1M | 53.98 | |
| Alder Biopharmaceuticals | 7.4 | $103M | 2.0M | 52.97 | |
| Nevro (NVRO) | 5.9 | $82M | 1.5M | 53.75 | |
| Flexion Therapeutics | 3.4 | $47M | 2.1M | 21.89 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 3.3 | $47M | 2.7M | 17.25 | |
| Adaptimmune Therapeutics Sponds Adr (ADAPY) | 2.3 | $32M | 1.8M | 18.33 | |
| Colucid Pharmaceuticals | 2.0 | $27M | 3.1M | 8.90 | |
| Otonomy | 1.4 | $20M | 875k | 22.99 | |
| Tokai Pharmaceuticals | 1.2 | $17M | 1.2M | 13.30 | |
| Akebia Therapeutics (AKBA) | 1.1 | $16M | 1.5M | 10.29 | |
| Htg Molecular Diagnostics | 1.0 | $14M | 1.3M | 11.15 | |
| Invuity | 0.8 | $11M | 741k | 14.12 | |
| Glaukos (GKOS) | 0.2 | $2.2M | 75k | 28.99 | |
| Aerie Pharmaceuticals | 0.1 | $1.8M | 100k | 17.65 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.5M | 128k | 11.53 |
